Reducing the need for carbohydrate counting in type 1 diabetes using closed-loop automated insulin delivery (artificial pancreas) and empagliflozin: A randomized, controlled, non-inferiority, crossover pilot trial - Haidar, A; Yale, JF; Lovblom, LE (Diabetes Obes Metab, 2021)
et al.